Nimish Shah

1.4k total citations
25 papers, 300 citations indexed

About

Nimish Shah is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Nimish Shah has authored 25 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 8 papers in Oncology and 6 papers in Genetics. Recurrent topics in Nimish Shah's work include Lymphoma Diagnosis and Treatment (13 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Viral-associated cancers and disorders (6 papers). Nimish Shah is often cited by papers focused on Lymphoma Diagnosis and Treatment (13 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Viral-associated cancers and disorders (6 papers). Nimish Shah collaborates with scholars based in United Kingdom, India and Australia. Nimish Shah's co-authors include Linda M. Zangwill, E. M. Hoffmann, F. A. Medeiros, Robert N. Weinreb, Christopher Bowd, Rajiv Baijal, Deepak Amarapurkar, Simon Rule, Madhuri Chandnani and Mayank Jain and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Nimish Shah

21 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nimish Shah United Kingdom 10 85 85 82 80 80 25 300
M. Adnaoui Morocco 11 18 0.2× 69 0.8× 55 0.7× 6 0.1× 31 0.4× 49 276
Benjamin Empson United Kingdom 2 35 0.4× 11 0.1× 14 0.2× 61 0.8× 17 0.2× 2 267
Paloma Triana Spain 11 104 1.2× 14 0.2× 20 0.2× 17 0.2× 27 0.3× 45 467
Da Teng China 10 121 1.4× 55 0.6× 19 0.2× 47 0.6× 13 0.2× 29 315
Ryan B. Schwope United States 10 49 0.6× 25 0.3× 190 2.3× 47 0.6× 130 1.6× 38 419
Alejandro Olivé Marquès Spain 7 34 0.4× 8 0.1× 42 0.5× 43 0.5× 8 0.1× 29 236
Harpreet S. Walia United States 8 14 0.2× 270 3.2× 38 0.5× 49 0.6× 5 0.1× 15 368
Haoting Zhan China 9 24 0.3× 28 0.3× 52 0.6× 10 0.1× 6 0.1× 38 300
Syahrul Sazliyana Shaharir Malaysia 13 44 0.5× 4 0.0× 25 0.3× 23 0.3× 20 0.3× 38 327
Amanda Saracino Australia 11 136 1.6× 16 0.2× 99 1.2× 35 0.4× 2 0.0× 17 358

Countries citing papers authored by Nimish Shah

Since Specialization
Citations

This map shows the geographic impact of Nimish Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nimish Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nimish Shah more than expected).

Fields of papers citing papers by Nimish Shah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nimish Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nimish Shah. The network helps show where Nimish Shah may publish in the future.

Co-authorship network of co-authors of Nimish Shah

This figure shows the co-authorship network connecting the top 25 collaborators of Nimish Shah. A scholar is included among the top collaborators of Nimish Shah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nimish Shah. Nimish Shah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khadela, Avinash, et al.. (2025). Emerging Role of Lenvatinib in Treating Platinum-Refractory Head and Neck Cancer in Resource-Limited Settings. Indian Journal of Medical and Paediatric Oncology. 46(5). 453–460.
3.
Lewis, Katharine L., Nimish Shah, Chan Y. Cheah, et al.. (2022). R-DA-EPOCH Treatment Is Highly Effective Therapy for Primary Mediastinal Large B-Cell Lymphoma: A Real-World Multi-Centre Retrospective Evaluation. Blood. 140(Supplement 1). 9551–9553. 2 indexed citations
4.
Eyre, Toby A., Sally F. Barrington, Jessica Okosun, et al.. (2022). Impact of positron emission tomography - computed tomography status on progression-free survival for relapsed follicular lymphoma patients undergoing autologous stem cell transplantation. Haematologica. 108(3). 785–796. 3 indexed citations
5.
Miah, Saiful, Martin J. Connor, Oliver Wiseman, & Nimish Shah. (2021). Retrograde migration of a vesicoureteric junction calculus: A potential pitfall of the noncontrast limited pelvic computerized tomography. Urology Annals. 13(1). 80–80. 2 indexed citations
7.
Wilson, Matthew R., Toby A. Eyre, Nicolás Martínez‐Calle, et al.. (2020). Timing of high-dose methotrexate CNS prophylaxis in DLBCL: an analysis of toxicity and impact on R-CHOP delivery. Blood Advances. 4(15). 3586–3593. 32 indexed citations
9.
Collins, Anne T., Chandan Saha, Vidyarani Shyamsundar, et al.. (2017). Advanced Hodgkin lymphoma in the east of England cancer network: A 10‐year comparative analysis of outcomes for ABVD and escalated‐BEACOPP treated patients aged 16 to 59. Hematological Oncology. 35(S2). 318–319. 1 indexed citations
10.
Shah, Apurva, Deepak Amarapurkar, Madhuri Chandnani, et al.. (2015). Coagulopathy in Cirrhosis: A Prospective Study to Correlate Conventional Tests of Coagulation and Bleeding Following Invasive Procedures in Cirrhotics. Clinical Gastroenterology and Hepatology. 13(7). e107–e108. 7 indexed citations
11.
Amarapurkar, Deepak, Madhuri Chandnani, Rajiv Baijal, et al.. (2015). Acute-on-chronic liver failure: A prospective study to determine the clinical profile, outcome, and factors predicting mortality. Indian Journal of Gastroenterology. 34(3). 216–224. 24 indexed citations
12.
Shah, Nimish, et al.. (2014). Clinical and investigative assessment of constipation: A study from a referral center in western India. Indian Journal of Gastroenterology. 33(6). 530–536. 19 indexed citations
13.
Baijal, Rajiv, Deepak Amarapurkar, Nimish Shah, et al.. (2014). A multicenter prospective study of infections related morbidity and mortality in cirrhosis of liver. Indian Journal of Gastroenterology. 33(4). 336–342. 26 indexed citations
14.
Shah, Nimish, Constantine S. Tam, John F. Seymour, & Simon Rule. (2014). How applicable is fludarabine, cyclophosphamide and rituximab to the elderly?. Leukemia & lymphoma. 56(6). 1599–1610. 10 indexed citations
15.
Shah, Nimish, Claire V. Hutchinson, & Simon Rule. (2014). Ibrutinib for the treatment of mantle cell lymphoma. Expert Review of Hematology. 7(5). 521–531. 10 indexed citations
16.
Dyer, Martin J.S., Claire V. Hutchinson, Simon Rule, et al.. (2014). The Bruton’s tyrosine kinase (BTK) inhibitor ONO-4059: Single-agent activity in patients with relapsed and refractory non-GCB-DLBCL.. Journal of Clinical Oncology. 32(15_suppl). 8553–8553. 5 indexed citations
17.
Furtado, Michelle, et al.. (2012). Abnormal serum free light chain ratio predicts poor overall survival in mantle cell lymphoma. British Journal of Haematology. 160(1). 63–69. 7 indexed citations
18.
Shah, Nimish, Christopher Bowd, F. A. Medeiros, et al.. (2006). Combining Structural and Functional Testing for Detection of Glaucoma. Ophthalmology. 113(9). 1593–1602. 85 indexed citations
19.
Alvarez, Walter C., et al.. (2003). 1013 Interferon treatment outcomes in patients with decompensated HCV + cirrhosis. Hepatology. 38. 644–645. 2 indexed citations
20.
Masood, Junaid, Nimish Shah, Tim Lane, & J.M. Barua. (2003). Urethral Catheter: A Pain in the Neck!. Urologia Internationalis. 70(4). 330–331. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026